153 related articles for article (PubMed ID: 1685568)
1. Effects of antipsychotic drugs on serotonin receptors.
Meltzer HY; Nash JF
Pharmacol Rev; 1991 Dec; 43(4):587-604. PubMed ID: 1685568
[No Abstract] [Full Text] [Related]
2. [Medicinal action and efficacy of neuroleptics].
Suzuki H; Akimoto T; Gen K; Aoba A
Ryoikibetsu Shokogun Shirizu; 2003; (38):169-71. PubMed ID: 12876957
[No Abstract] [Full Text] [Related]
3. Effects of clozapine and other neuroleptics on binding of [3H]-Q ICS 205-930 to central 5-HT3 recognition sites.
Watling KJ; Beer MS; Stanton JA
Br J Pharmacol; 1989 Dec; 98 Suppl():813P. PubMed ID: 2575419
[No Abstract] [Full Text] [Related]
4. [The types of central serotonin receptors, their functional role and participation in the action of psychopharmacologic agents].
Abramets II
Farmakol Toksikol; 1990; 53(5):70-5. PubMed ID: 1979281
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review.
Meltzer HY
Br J Psychiatry Suppl; 1996 May; (29):23-31. PubMed ID: 8733820
[No Abstract] [Full Text] [Related]
6. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
Bacopoulos NG
J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
[TBL] [Abstract][Full Text] [Related]
7. [Current concepts of the effects of neuroleptics].
Kostowski W; Płaźnik A
Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
[No Abstract] [Full Text] [Related]
8. Receptor pharmacology of neuroleptics: relation to clinical effects.
Richelson E
J Clin Psychiatry; 1999; 60 Suppl 10():5-14. PubMed ID: 10340682
[TBL] [Abstract][Full Text] [Related]
9. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
10. 5-HT6 receptor ligands and their antipsychotic potential.
Arnt J; Olsen CK
Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
[No Abstract] [Full Text] [Related]
11. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
[TBL] [Abstract][Full Text] [Related]
12. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
Matsubara R
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
[TBL] [Abstract][Full Text] [Related]
13. Serotonin receptor and reuptake sites: pharmacologic significance.
Gonzalez-Heydrich J; Peroutka SJ
J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
[TBL] [Abstract][Full Text] [Related]
14. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
15. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
16. Serotonin receptor binding sites: is there pharmacological and clinical significance?
Leysen J
Med Biol; 1983 Jun; 61(3):139-43. PubMed ID: 6314066
[No Abstract] [Full Text] [Related]
17. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
Koe BK
J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
[TBL] [Abstract][Full Text] [Related]
18. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
Kuroki T; Meltzer HY; Ichikawa J
J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
[TBL] [Abstract][Full Text] [Related]
19. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
[TBL] [Abstract][Full Text] [Related]
20. Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.
Schmidt CJ; Kehne JH; Carr AA; Fadayel GM; Humphreys TM; Kettler HJ; McCloskey TC; Padich RA; Taylor VL; Sorensen SM
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():25-32. PubMed ID: 7911139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
